| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458447A2 Combination of cytochome p 450 dependent protease inhibitors |
| 09/22/2004 | EP1458401A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std) |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458391A1 A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458373A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 09/22/2004 | EP1458367A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458353A1 Formulation dosage form for the controlled delivery of ther apeutic agents |
| 09/22/2004 | EP1458337A1 Stable surfactant compositions for suspending components |
| 09/22/2004 | EP1373298B1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 09/22/2004 | EP1268475B1 Novel benzosultam oxazolidinone antibacterial agents |
| 09/22/2004 | EP1242073B1 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 09/22/2004 | EP1227096B1 4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1201678B1 Novel bicyclonucleoside analogues |
| 09/22/2004 | EP1187631B1 Prevention of type 1 diabetes and other non-polio enterovirus diseases |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1140160B1 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 09/22/2004 | EP1135161B1 Chemotherapeutic composition and method |
| 09/22/2004 | EP1042340B1 6-o-alkyl erythromycin b oxime |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP0975774B1 Bacterial plasmids |
| 09/22/2004 | EP0914442B1 Avian polynucleotide vaccine formula |
| 09/22/2004 | EP0854925B1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531548A Chimeric chains that code for proteins that induce effects directed against viruses |
| 09/22/2004 | CN1531547A Hepatitis C tripeptide inhibitors |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531442A Perylenequinones for use as photosensitizers and sonosensitizers |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531430A Local used composition containing antifungal agent |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530372A Inhibitor of hecterocyclic oxoaminoethylol aminosulfonic amine reverse transcripted virus protenase |
| 09/22/2004 | CN1530370A Intermediate and process for preparation of 4''-substituted-9A-deoxy-9A-aza-erythromycin derivative |
| 09/22/2004 | CN1530136A Medicine feeding method for antibiotics |
| 09/22/2004 | CN1530124A 硫磺散 Sulfur Powder |
| 09/22/2004 | CN1530123A Chinese medicine for treating acute appendicitis and chronic appendicitis, preparing method thereof |
| 09/22/2004 | CN1530109A Use of oxidized matrine in preparation of chemicals for treating viral myocarditis |
| 09/22/2004 | CN1530108A Use of oxidized matrine in preparatino of chemicals for treating venereal diseases |
| 09/22/2004 | CN1530098A Local preparation for remitting pains and inflammation caused by nerpes virus |
| 09/22/2004 | CN1167708C Prepn. process of 4''-substituted 9-deoxy-9A aza-9A homoerythromycin derivative |
| 09/22/2004 | CN1167700C Triazole derivative possessing anti-fungus activity |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167680C Fused-ring compounds and use thereof as drugs |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167452C Medicine for AIDS |
| 09/22/2004 | CN1167442C Medicine for treating AIDS and its preparing process |
| 09/22/2004 | CN1167419C Bifonazole containing medicinal composition |
| 09/22/2004 | CN1167413C Aerosol ointment compositions and preparation thereof |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794498 Method of eliminating inhibitory/instability regions of mRNA |
| 09/21/2004 | US6794490 Lipopeptides as antibacterial agents |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794372 Nitrate salts of antimicrobial agents |
| 09/21/2004 | US6794366 Macrolide antiinfective agents |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/21/2004 | US6793932 Includes at least one keratolytic and cerumenilytic cleaning agent, one bactericide agent, one yeast control agent and one anti-irritant and anti-pruriginous agent; for ear hygiene and for the prevention of otitis in dogs and cats |
| 09/21/2004 | US6793928 Vaccines with an LTB adjuvant |
| 09/21/2004 | US6793925 Pseudomycin natural products |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793921 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 09/21/2004 | CA2458085A1 Transcriptional activity assay |
| 09/21/2004 | CA2422972A1 Isopropanolate of azithromycin and method of manufacturing |
| 09/21/2004 | CA2200316C Imidazole derivative |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/16/2004 | WO2004078974A1 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 09/16/2004 | WO2004078912A2 Chicken rna polymerase i promoter and the use thereof |
| 09/16/2004 | WO2004078771A1 2-fluoro-6-o-substituted ketolide derivative |
| 09/16/2004 | WO2004078770A1 Bifunctional heterocyclic compounds and methods of making and using the same |
| 09/16/2004 | WO2004078753A1 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 09/16/2004 | WO2004078206A1 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/16/2004 | WO2004078191A1 Composition for treating hepatitis c |
| 09/16/2004 | WO2004078181A1 Rna interference based methods and compositions for inhibiting hbv gene expression |
| 09/16/2004 | WO2004078179A1 Combination therapy for infectious disease |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004069140A3 Antigen imitating extracellular areas of membrane proteins of type iii produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 09/16/2004 | WO2004065406A3 Rantes-derived peptides with anti-hiv activity |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004056380A3 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation |